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small bowel, hepatobiliary tract, pancreas, and upper uro-epithelial
tract (Lynch and de la Chapelle, 2003). In 1991, an international collab-
orative initiative ratiﬁed the Amsterdam Criteria for diagnosing LS
(Vasen et al., 1991), and in 1999 these were expanded to include
extra-colonic tumors (Vasen et al., 1999). During the early 21st century,
Bethesda Guidelines were developed to triage CRC patients for prelimi-
nary testing for LS (Lynch and de la Chapelle, 2003).
The ﬁrst cancer susceptibility locus for LS was mapped to chromo-
some 2p by Peltomaki et al. in 1993 through a genome-wide search
and linkage analysis in large informative families (Peltomaki et al.,
1993). During that same year, a second locus was identiﬁed on chromo-
some 3p by Lindblom et al. (1993). LS tumors are characterized byChapelle, 2003). Ultimately, the ﬁrst two LS genes, MSH2 and MLH1,Introduction
Although the ﬁrst clinical report of hereditary colorectal cancer
(CRC) was published in 1861, this patient likely had familial adenoma-
tous polyposis (Luschka, 1861). This was followed in 1913 with
Warthin's publication of a large pedigree (Family G) which included
many cases of CRC in the absence of polyposis aswell as uterine and gas-
tric cancer (As, 1913). Over half a century later, Lynch et al. reported two
large Midwestern kindreds from Nebraska and Michigan (Families N
and M) whose constellation of malignancies was comprised of tumors
similar to Family G (Lynch et al., 1966). Scrutinization of these three
families (G, N andM), alongwith the careful study of hundreds of others
that followed, helped to deﬁne the cardinal features of Lynch syndrome
(LS).
LS has an autosomal dominant inheritance pattern with earlier
average age (mean age 44) of CRC onset than the general population.
There is increased risk of extra-colonic malignancy including theology, Department of Obstetrics
omprehensive Cancer Center,
ty Dr. South, Building 56 Room
en access article under the CC BY-NCmicrosatellite instability (MSI), a consequence of defective DNA replica-
tion error repair or post-synthetic DNA proofreading (Lynch and de la
were identiﬁed on chromosomes 2p and 3p, respectively. Themismatch
repair (MMR) complex also includes MSH6, PMS2, and possibly MLH3
(Lynch and de la Chapelle, 2003).
MMR gene mutations account for 3–5% of all colorectal cancer cases,
and 2–6% of all endometrial cancers (Bronner et al., 1994). Nearly 51% of
women with LS present with endometrial cancer as their ﬁrst primary
carcinoma (Fishel et al., 1993). Because poor patient recall, cultural
barriers in communication, and inadequate healthcare documentation
impact the sensitivity of both the Amsterdam Criteria and Bethesda
Guidelines, the Society of Gynecologic Oncology has modiﬁed the
Amsterdam Criteria by including personal/familial history of uterine/
ovarian cancer to improve identiﬁcation of mutation carriers (Lancaster
et al., 2007). “Universal screening” of tumor tissue for MSI and immuno-
histochemistry to detect LS-related mutations may be particularly im-
portant among endometrial cancer patients diagnosed under 55 years.
Background on Vietnamese Immigration to the U.S.
The Fall of Saigon on April 30, 1975 ended the Vietnam War
prompting three, successive, large-scale waves of Vietnamese immigra-
tion to the United States (Allen and Hiller, 1985). These were supported
by President Gerald Ford, who passed the Indochina Migration and
Refugee Assistance Act in 1975 (Allen and Hiller, 1985). Currently,
there are approximately 1.5 million Vietnamese–Americans, with-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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www.census.gov). The largest numbers of Vietnamese outside of
Vietnam reside in Orange County, California. Most are small business
owners in Little Saigon (Allen and Hiller, 1985). The growth-rate of
the Vietnamese population in the US was 37.9% between 2000 and
2010.
China's character cultural sphere, known as the sinosphere,
comprises those regions of the world such as China, Taiwan, Japan,
Korea, and Vietnam, where Chinese characters are found suggesting
co-mingling of the cultures. Cultural immersion often parallels gene
sharing. While there are many cases of LS occurring in the Chinese
population, and several publications involving both Japanese and
Korean families, to our knowledge, LS has not been previously reported
in a Vietnamese kindred (PUBMED Medline Search).
Case Histories: Proband Medical History
Patient #1 is a 57 year-old female who ﬂed Vietnam in 1980. In
February 2010 she was found to have an 8 cm complex right adnexal
mass on ultrasound. She did not report any postmenopausal vaginal
bleeding or gastrointestinal symptomatology. A pre-operative computed
tomography (CT) scan demonstrated the pelvic mass and a mid-colonic
lesion. The patient underwent open hysterectomy, bilateral salpingo-oo-
phorectomy, omentectomy, pelvic/para-aortic lymphadenectomy
and transverse colectomy with primary anastomosis. Pathology wasFig. 1. Vietnamese–American kindred family pedigree. A total of 9 cases of carcinoma, occurrin
colon cancer. Subject III–VI had uterine cancer. Subject III–IV was diagnosed with colon cance
one (III–VII) carries the deleterious MSH2 mutation. Lastly, subject IV–VI elected to proceed w
deleterious mutation.consistentwith 3 synchronous lesions: FIGO stage IA grade 1 endometrial
carcinoma, FIGO IC clear cell ovarian carcinoma, and stage I adenocarcino-
ma of the colon. She received adjuvant platinum- plus taxane-based
intravenous chemotherapy.
In October 2012, the proband's sister Patient #2 reportedmenorrha-
gia andwas diagnosedwith grade 2 endometrioid adenocarcinoma. She
was referred to the same Gynecologic Oncologist that cared for her
sister and provided a more detailed family history (colon cancer in her
brother (age 49) and maternal pancreatic cancer (deceased age 48).
She underwent a robotic hysterectomy with bilateral salpingo-
oophorectomy and lymphadenectomy. Final pathology revealed
a FIGO stage IA, grade 2 endometrioid adenocarcinoma with no
lymphovascular space invasion. IHC screening of the tumor for MLH1,
MSH2, MSH6, and PMS2 was positive for LS. Both sisters and their
brother were referred for genetic counseling.
Case Histories: Vietnamese–American Kindred
A comprehensive family pedigree was created (Fig. 1) which
demonstrated 9 cases of carcinoma occurring over 3 generations. The
proband (subject III–II) had 8 siblings, and of these, 2 had a diagnosis of
carcinoma (including her sister, subject III–VI, described above).
Independent genetic testing conﬁrmed an MSH2 mutation (L634X
(1901T N G) in the proband, her sister, and additional unaffected brother
(III–VII) (Fig. 2).g over 3 generations were identiﬁed. Subject III–II had synchronous ovarian, uterine and
r but has not had genetic testing. Three unaffected family members have been tested and
ith genetic counseling and testing at age 24 and was conﬁrmed to carry the same MSH2
Fig. 2. Sequencing studies with wild type thymine (T) to guanine (G) transition at amino
acid 1901, of codon 634 in exon 12 (L634X (1901T NG). This single sitemutation results in
insertion of a UGA stop codon and premature truncation of theMSH2 protein product.
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codon 634 of exon 12, and resulted in premature truncation of the
MSH2 protein, with stop codon UGA substituted for UUA, which
normally codes for amino acid leucine. Subject III–IV's son (IV–VI)
(age 24) underwent counseling/testing and was found to carry the
samedeleteriousmutation. Affected familymembers have been advised
to undergo colonoscopy every 1–2 years, upper endoscopy with
extended duodenoscopy every 3–5 years, annual urinalysis, and annual
physical examination.
Discussion
The DNA MMR system plays a pivotal role in eliminating the mis-
match of base–base insertions and deletions resulting from polymerase
errors duringDNA synthesis. TheMMRgenes are also involved in ensur-
ing the ﬁdelity of genetic recombination, and facilitating the apoptotic
response to DNA damage.
Together, the MMR gene products function as heterodimers. Nearly
80% ofMSH2 is found in a complex involvingMSH2–MSH6, and it func-
tions to recognize the mismatch of base–base insertions and deletions,
and can also recognize large deletions and insertions. Mutations in
MSH2 have been reported in 36% of MMR germline variants (Moline
et al., 2013). While most variants are nonsense or frameshift mutations
that do not yield a stable protein product, 18% of MSH2 variants are
missense variants that may affect only a single amino acid.
While truncatedMSH2 protein product has been reported previously
in the MSH2 initiation codon on chromosome 2p16, in the kindred we
have described that the truncated protein is a result of a mutation
more downstream in exon 12 that results in premature truncation of
the protein at amino acid 634. In the absence of mutation, the MSH2–
MSH6 heterodimer binds to single-base mispairs or insertions via paired
N-terminal mismatch binding domains, while theMSH2–MSH3 binds to
larger insertion/deletion loops in DNA (Peltomaki, 2003). It is not known
whether the truncated MSH2 protein resulting from our kindred's
mutation will affect the binding and/or biochemical activity of the
MSH2–MSH6 or MSH2–MSH3 heterodimers.
The truncated product lacks evolutionary domains required forMSH6
interaction, DNA binding and ultimately excision repair (Lynch and de la
Chapelle, 2003; Peltomaki, 2003). The identiﬁcation of mutation carrier
status is of signiﬁcant clinical importance, as there are clear implications
for all members of the family. Speciﬁcally, institution of appropriatescreening measures, as well as risk reducing surgery (hysterectomy
and bilateral salping-oophorectomy, subtotal colectomy), where
appropriate, may translate into prevention and/or early detection of
LS-related cancers. Identiﬁcation of non-carriers will alleviate anxiety
and prevent unnecessary procedures. Lack of healthcare insurance and
ﬁnancial hardships related to co-pays have been the primary obstacles
to comprehensive family testing.
The societal and medical implications of delayed diagnosis in the
Vietnamese–American population are implicit, and implementation of
appropriate screening algorithms has gained attention in recent years.
It is recognized from survey-based studies conducted over the past
15 years that the Vietnamese–American population lags behind other
Asian groups in general health maintenance, health-related education
and cancer screening. Studies exploring adherence to mammography
and cervical cancer screening describe one of the most commonly re-
ported barriers as lack of physician/health care provider education
(McPhee et al., 1997). Programs utilizing lay health care workers and
media education, created and implemented in both California and
Texas, have shown promise by signiﬁcantly increasing the rates of
receipt and maintenance of breast and cervical cancer screening tests.
This report details the identiﬁcation of anMSH2mutation in a large
Vietnamese kindred, and highlights the importance of physician and
patient awareness. Moving forward, local and state-based databases will
be mined in an effort to detect familial cancer trends in this population
that had gone previously unrecognized. Additionally, the development
of culturally sensitive community outreach and awareness programs in
order to promote recognition and education will be a priority. Identiﬁca-
tion and appropriate counseling as they relate to hereditary cancer
syndromes are imperative.Conﬂict of interest
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